Healthcare Services

Autoimmune Disease Diagnosis Market Growth Outlook Indicating Expansion To $9.37 Billion By 2030

May 27, 2026June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Increase In Market Value Is Predicted For The Autoimmune Disease Diagnosis Market During The 2026–2030 Period?

The autoimmune disease diagnosis market has experienced robust expansion in recent years. It is projected to grow from $6.2 billion in 2025 to $6.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. This historical development can be attributed to the increasing prevalence of autoimmune diseases, enhanced availability of immunoassay technologies, the expansion of clinical laboratory networks, growing physician awareness of autoimmune conditions, and wider adoption of routine screening tests.

The autoimmune disease diagnosis market size is anticipated to undergo substantial growth in the upcoming years. It is projected to reach $9.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. The expansion during this forecast period can be attributed to an increasing demand for early and accurate diagnosis, the rising adoption of AI-assisted diagnostic analytics, the broadening of personalized diagnostic approaches, growing investments in autoimmune research, and the enhanced integration of point-of-care testing. Key trends expected in the forecast period encompass the increasing uptake of advanced immunological testing, a rising utilization of autoantibody panels, the growing incorporation of multiplex diagnostic platforms, the expansion of laboratory automation, and an enhanced focus on early disease detection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp

What Important Drivers Are Powering The Autoimmune Disease Diagnosis Market Growth?

The high occurrence of autoimmune diseases has fueled the expansion of the autoimmune disease diagnosis market. Autoimmune diseases are conditions where the body’s immune system mistakenly attacks its own healthy cells, tissues, or organs. These diseases are increasing due to rising exposure to environmental elements such as pollution, infections, and lifestyle changes that can disrupt immune regulation. Autoimmune disease diagnosis serves to accurately identify the specific immune disorder, allowing for timely treatment initiation and improved management of disease progression. For instance, in March 2023, the Society for Women’s Health Research, a U.S-based non-profit organisation, reported that an estimated 23.5 million to 50 million people are affected by autoimmune diseases. Furthermore, global autoimmune disease rates are climbing by 3-9 percent annually. Thus, the escalating worldwide incidence of autoimmune diseases is a key driver for the growth of the autoimmune disease diagnosis market.

Which Segment Groups Define The Autoimmune Disease Diagnosis Market Landscape?

The autoimmune disease diagnosis market covered in this report is segmented –

1) By Product: Consumables And Assay Kits, Instruments

2) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests

3) By End User: Clinical Laboratories, Hospitals, Other End Users

Subsegments:

1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials

2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes

Which Trends Are Expected To Shape The Autoimmune Disease Diagnosis Market?

Leading companies in the autoimmune disease diagnosis market are concentrating on developing technological advancements, specifically multiplex autoantibody assay platforms, to achieve comprehensive, early, and precise detection of autoimmune disorders, ultimately improving diagnostic accuracy and patient management. Such platforms facilitate the simultaneous identification of multiple disease-specific autoantibodies from a single patient sample, significantly enhancing sensitivity and specificity compared to traditional single-analyte ELISA or immunofluorescence tests, while also reducing required sample volume and processing time. An instance of this is Exagen Inc., a U.S.-based diagnostics company, which launched its AVISE CTD platform in January 2025, featuring new systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) biomarker assays. This platform detects novel biomarkers such as TIgG, TIgM, and TC4d, enabling clinicians to more accurately distinguish overlapping autoimmune conditions and streamline patient diagnosis, all while integrating seamlessly with existing testing workflows.

Which Firms Are Competing In The Autoimmune Disease Diagnosis Market?

Major companies operating in the autoimmune disease diagnosis market are Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc, bioMérieux SA, SQI Diagnostics, Philips Healthcare India, Agappe Diagnostics Ltd, Lepu Medical Technology Company (Beijing) Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Becton Dickinson and Company, Ortho Clinical Diagnostics

Access The Complete Autoimmune Disease Diagnosis Market Report:

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Which Region Stands As The Largest Contributor To The Autoimmune Disease Diagnosis Market?

North America was the largest region in the autoimmune disease diagnosis market in 2025. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Autoimmune Disease Diagnosis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=3231&type=smp

Browse Through More Reports Similar to the Global Autoimmune Disease Diagnosis Market 2026, By The Business Research Company

Autoimmune Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Immunodiagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Veterinary Autoimmune Disease Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795